Physician profile
Daniel Adams
NPI 1326345257
$242,459.66
in general payments reported to CMS, 2019-2025
20 companies · $239K in 2025
The $239K reported for 2025 was more than what 99% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $222 · 2021: $172 · 2022: $336 · 2023: $1,548 · 2024: $366 · 2025: $239K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240K · Travel and Lodging: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239,916.83 |
| Travel and Lodging | $1,428.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Route 92 Medical, INC. | $239,058.00 | 2025 | |
| Ge Healthcare | $1,428.18 | 2023 | |
| Boston Scientific Corporation | $598.21 | 2020-2025 | General - Interventional Oncology, Embold Fibered, Icefx Cryoablation System |
| Merit Medical Systems INC | $347.63 | 2019 | |
| Inari Medical, INC. | $230.92 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $183.10 | 2024-2025 | Red 72 |
| Depuy Synthes Sales INC. | $108.40 | 2025 | Embotrap |
| Venclose INC. | $85.70 | 2020 | |
| Sirtex Medical INC | $73.31 | 2019-2020 | |
| Stryker Corporation | $51.19 | 2022-2024 | Target |
| Argon Medical Devices, INC. | $46.46 | 2023 | Skater |
| Trisalus Life Sciences, INC. | $45.10 | 2024-2025 | Trinav Infusion System |
| Siemens Medical Solutions USA, INC. | $39.64 | 2024 | |
| Angiodynamics, INC. | $37.28 | 2023 | Venacure 1470 Pro |
| Abiomed | $29.92 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $26.43 | 2020 | |
| Surmodics, INC. | $23.60 | 2022 | |
| Medtronic, INC. | $22.48 | 2021 | |
| Organogenesis INC. | $12.63 | 2022 | |
| Bard Peripheral Vascular, INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.